Jun 14, 2022 · When the cytomegalovirus (CMV) virus leads to liver problems, it's called CMV hepatitis. Learn about risk factors, symptoms, diagnosis, and treatment.

Mar 23, 2022 · CMV spreads from person to person through body fluids, such as blood, saliva, urine, semen and breast milk. There is no cure, but there are medications that can help treat the symptoms. Most healthy people who are infected with CMV may experience no symptoms. Some experience minor symptoms.

In the liver, CMV most frequently infects hepatocytes and macrophages, whereas stromal and vascular endothelial cells are the primary target in the gastrointestinal (GI) tract [6–8].

Jan 17, 2025 · Occasionally, CMV can cause mononucleosis or hepatitis (liver problems). If you have a weakened immune system and get CMV, you can have more serious symptoms affecting the eyes; lungs; liver; esophagus; stomach; and intestines. Babies born with CMV can have brain, liver, spleen, lung, and growth problems.

Acute CMV infection was diagnosed by positive CMV antibody and polymerase chain reaction (PCR) testing. The patient was treated with valganciclovir that resulted in rapid improvement in clinical status as well as normalization of the liver enzymes.

May 16, 2024 · The diagnosis and monitoring of CMV infection and tissue-invasive disease will be discussed here, with an emphasis on the role of diagnostic tests and their strengths and limitations. An overview of the diagnostic tests for CMV is presented separately.

Oct 20, 2022 · CMV can cause serious complications in people who have a compromised immune system, such as transplant recipients. What is cytomegalovirus? Cytomegalovirus (CMV) is an illness you get from a herpes virus (an organism that …

Feb 1, 2003 · Elevation of liver transaminase levels is a common feature of acute CMV infection, occurring in up to 92 percent of patients, and often it can be mistaken for acute hepatitis.

Jun 22, 2023 · Cytomegalovirus (CMV) hepatitis is an infection of the liver caused by cytomegalovirus, causing liver damage, ranging from asymptomatic to liver inflammation, failure and even death.

Much of medical literature implicating CMV as the causative agent for hepatitis involves either immunocompromised hosts or previous orthotopic liver transplant recipients. In these cases, the incidence of CMV hepatitis runs from as low as 2–17% to as high as 34%.